A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously “undruggable” target.
Tests that provide molecular details on a specific tumor aren’t routinely done for pediatric brain tumors, but research suggests the extra step could change a child’s therapy.
A subset of patients known as maximizers consume a high level of medical resources without clear evidence of better outcomes, a study found.
Speaking directly with a pathologist could help patients better understand their diagnosis and feel empowered, a survey of patient sentiment finds.
Learning health care systems using electronic medical records for quality improvement and research should first seek patient consent.
Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.